These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 28554411)
1. Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease. Johar I; Mollenhauer B; Aarsland D Int Rev Neurobiol; 2017; 132():275-294. PubMed ID: 28554411 [TBL] [Abstract][Full Text] [Related]
2. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease. Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633 [TBL] [Abstract][Full Text] [Related]
3. Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease. Skogseth RE; Bronnick K; Pereira JB; Mollenhauer B; Weintraub D; Fladby T; Aarsland D J Parkinsons Dis; 2015; 5(4):783-92. PubMed ID: 26599300 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study. Liu T; Zuo H; Ma D; Song D; Zhao Y; Cheng O J Neuroinflammation; 2023 Jul; 20(1):167. PubMed ID: 37475029 [TBL] [Abstract][Full Text] [Related]
5. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders. Mollenhauer B; Parnetti L; Rektorova I; Kramberger MG; Pikkarainen M; Schulz-Schaeffer WJ; Aarsland D; Svenningsson P; Farotti L; Verbeek MM; Schlossmacher MG J Neurochem; 2016 Oct; 139 Suppl 1():290-317. PubMed ID: 26452984 [TBL] [Abstract][Full Text] [Related]
6. Changes of cerebrospinal fluid Aβ Hu X; Yang Y; Gong D Neurol Sci; 2017 Nov; 38(11):1953-1961. PubMed ID: 28808876 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients. Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563 [TBL] [Abstract][Full Text] [Related]
13. Baseline concentration of misfolded α-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson's disease. Ning H; Wu Q; Han D; Yao T; Wang J; Lu W; Lv S; Jia Q; Li X Neuropathol Appl Neurobiol; 2019 Jun; 45(4):398-409. PubMed ID: 30346044 [TBL] [Abstract][Full Text] [Related]
15. Measurement of CSF α-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease. García-Ayllón MS; Monge-Argilés JA; Monge-García V; Navarrete F; Cortés-Gómez MA; Sánchez-Payá J; Manzanares J; Gasparini-Berenguer R; Leiva-Santana C; Sáez-Valero J J Neurochem; 2019 Jul; 150(2):218-230. PubMed ID: 31077373 [TBL] [Abstract][Full Text] [Related]
16. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease. Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875 [TBL] [Abstract][Full Text] [Related]
17. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease. van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease. Bäckström DC; Eriksson Domellöf M; Linder J; Olsson B; Öhrfelt A; Trupp M; Zetterberg H; Blennow K; Forsgren L JAMA Neurol; 2015 Oct; 72(10):1175-82. PubMed ID: 26258692 [TBL] [Abstract][Full Text] [Related]
19. Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review. Leaver K; Poston KL Neuropsychol Rev; 2015 Dec; 25(4):411-23. PubMed ID: 26626621 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]